These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 19799958)

  • 21. Recent advances in cell-penetrating, non-peptide molecular carriers.
    Chung SK; Maiti KK; Lee WS
    Int J Pharm; 2008 Apr; 354(1-2):16-22. PubMed ID: 17890027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitatively determined uptake of cell-penetrating peptides in non-mammalian cells with an evaluation of degradation and antimicrobial effects.
    Palm C; Netzereab S; Hällbrink M
    Peptides; 2006 Jul; 27(7):1710-6. PubMed ID: 16500001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Creation of a novel cell penetrating peptide, using a random 18mer peptides library.
    Nomura T; Kawamura M; Shibata H; Abe Y; Ohkawa A; Mukai Y; Sugita T; Imai S; Nagano K; Okamoto T; Tsutsumi Y; Kamada H; Nakagawa S; Tsunoda S
    Pharmazie; 2007 Aug; 62(8):569-73. PubMed ID: 17867548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of cell-penetrating peptides as a tool for gene regulation.
    Järver P; Langel U
    Drug Discov Today; 2004 May; 9(9):395-402. PubMed ID: 15081956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell-penetrating peptides for drug delivery across membrane barriers.
    Foged C; Nielsen HM
    Expert Opin Drug Deliv; 2008 Jan; 5(1):105-17. PubMed ID: 18095931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent advances in the use of cell-penetrating peptides for medical and biological applications.
    Fonseca SB; Pereira MP; Kelley SO
    Adv Drug Deliv Rev; 2009 Sep; 61(11):953-64. PubMed ID: 19538995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of cell-penetrating peptides for drug delivery.
    Temsamani J; Vidal P
    Drug Discov Today; 2004 Dec; 9(23):1012-9. PubMed ID: 15574317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell-penetrating peptides as delivery vehicles for biology and medicine.
    Stewart KM; Horton KL; Kelley SO
    Org Biomol Chem; 2008 Jul; 6(13):2242-55. PubMed ID: 18563254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uptake of cell-penetrating peptides is dependent on peptide-to-cell ratio rather than on peptide concentration.
    Hällbrink M; Oehlke J; Papsdorf G; Bienert M
    Biochim Biophys Acta; 2004 Dec; 1667(2):222-8. PubMed ID: 15581859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biological responses towards cationic peptides and drug carriers.
    Verdurmen WP; Brock R
    Trends Pharmacol Sci; 2011 Feb; 32(2):116-24. PubMed ID: 21167610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cellular siRNA delivery using cell-penetrating peptides modified for endosomal escape.
    Endoh T; Ohtsuki T
    Adv Drug Deliv Rev; 2009 Jul; 61(9):704-9. PubMed ID: 19383521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design of a tumor-homing cell-penetrating peptide.
    Myrberg H; Zhang L; Mäe M; Langel U
    Bioconjug Chem; 2008 Jan; 19(1):70-5. PubMed ID: 18001077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Construction of arginine-rich peptide displaying bionanocapsules.
    Shishido T; Yonezawa D; Iwata K; Tanaka T; Ogino C; Fukuda H; Kondo A
    Bioorg Med Chem Lett; 2009 Mar; 19(5):1473-6. PubMed ID: 19200722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein delivery by the cell-penetrating peptide YTA2.
    Myrberg H; Lindgren M; Langel U
    Bioconjug Chem; 2007; 18(1):170-4. PubMed ID: 17226970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemokine-derived peptides as carriers for gene delivery to CXCR4 expressing cells.
    Egorova A; Kiselev A; Hakli M; Ruponen M; Baranov V; Urtti A
    J Gene Med; 2009 Sep; 11(9):772-81. PubMed ID: 19562713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methodological and cellular aspects that govern the internalization mechanisms of arginine-rich cell-penetrating peptides.
    Nakase I; Takeuchi T; Tanaka G; Futaki S
    Adv Drug Deliv Rev; 2008 Mar; 60(4-5):598-607. PubMed ID: 18045727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Passage of cell-penetrating peptides across a human epithelial cell layer in vitro.
    Lindgren ME; Hällbrink MM; Elmquist AM; Langel U
    Biochem J; 2004 Jan; 377(Pt 1):69-76. PubMed ID: 12968950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Classes and prediction of cell-penetrating peptides.
    Lindgren M; Langel U
    Methods Mol Biol; 2011; 683():3-19. PubMed ID: 21053118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Second generation, arginine-rich (R-X'-R)(4)-type cell-penetrating α-ω-α-peptides with constrained, chiral ω-amino acids (X') for enhanced cargo delivery into cells.
    Patil KM; Naik RJ; Vij M; Yadav AK; Kumar VA; Ganguli M; Fernandes M
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4198-202. PubMed ID: 25096299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cargo-dependent cytotoxicity and delivery efficacy of cell-penetrating peptides: a comparative study.
    El-Andaloussi S; Järver P; Johansson HJ; Langel U
    Biochem J; 2007 Oct; 407(2):285-92. PubMed ID: 17627607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.